269 related articles for article (PubMed ID: 25058880)
1. Expression of estrogen-induced genes and estrogen receptor β in pancreatic neuroendocrine tumors: implications for targeted therapy.
Estrella JS; Ma LT; Milton DR; Yao JC; Wang H; Rashid A; Broaddus RR
Pancreas; 2014 Oct; 43(7):996-1002. PubMed ID: 25058880
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors.
Estrella JS; Broaddus RR; Mathews A; Milton DR; Yao JC; Wang H; Rashid A
Arch Pathol Lab Med; 2014 Aug; 138(8):1027-36. PubMed ID: 25076292
[TBL] [Abstract][Full Text] [Related]
3. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
[TBL] [Abstract][Full Text] [Related]
4. MEL-18 loss mediates estrogen receptor-α downregulation and hormone independence.
Lee JY; Won HY; Park JH; Kim HY; Choi HJ; Shin DH; Kang JH; Woo JK; Oh SH; Son T; Choi JW; Kim S; Kim HY; Yi K; Jang KS; Oh YH; Kong G
J Clin Invest; 2015 May; 125(5):1801-14. PubMed ID: 25822021
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
6. IGF-II mRNA expression in breast cancer: predictive value and relationship to other prognostic factors.
Fiore E; Campani D; Muller I; Belardi V; Giustarini E; Rossi G; Pinchera A; Giani C
Int J Biol Markers; 2010; 25(3):150-6. PubMed ID: 20677165
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
8. Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.
Bièche I; Parfait B; Laurendeau I; Girault I; Vidaud M; Lidereau R
Oncogene; 2001 Dec; 20(56):8109-15. PubMed ID: 11781824
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
Farrell JM; Pang JC; Kim GE; Tabatabai ZL
Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-1 content and pattern of expression correlates with histopathologic grade in diffusely infiltrating astrocytomas.
Hirano H; Lopes MB; Laws ER; Asakura T; Goto M; Carpenter JE; Karns LR; VandenBerg SR
Neuro Oncol; 1999 Apr; 1(2):109-19. PubMed ID: 11550306
[TBL] [Abstract][Full Text] [Related]
11. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
[TBL] [Abstract][Full Text] [Related]
12. DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors.
Park JK; Paik WH; Lee K; Ryu JK; Lee SH; Kim YT
Oncotarget; 2017 Jul; 8(30):49796-49806. PubMed ID: 28591701
[TBL] [Abstract][Full Text] [Related]
13. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
14. Molecular clustering based on ERα and EIG121 predicts survival in high-grade serous carcinoma of the ovary/peritoneum.
Schlumbrecht MP; Xie SS; Shipley GL; Urbauer DL; Broaddus RR
Mod Pathol; 2011 Mar; 24(3):453-62. PubMed ID: 21102415
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
Deng L; Broaddus RR; McCampbell A; Shipley GL; Loose DS; Stancel GM; Pickar JH; Davies PJ
Clin Cancer Res; 2005 Dec; 11(23):8258-64. PubMed ID: 16322283
[TBL] [Abstract][Full Text] [Related]
16. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
17. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease.
Lopez-Aguiar AG; Ethun CG; Postlewait LM; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2018 Jan; 25(1):290-298. PubMed ID: 29079920
[TBL] [Abstract][Full Text] [Related]
18. High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancer.
Horimoto Y; Sasahara N; Sasaki R; Hlaing MT; Sakaguchi A; Saeki H; Arakawa A; Himuro T; Saito M
Breast Cancer Res Treat; 2020 Aug; 183(1):41-48. PubMed ID: 32572714
[TBL] [Abstract][Full Text] [Related]
19. mRNA expression patterns of insulin-like growth factor system components in human neuroendocrine tumours.
Wulbrand U; Remmert G; Zöfel P; Wied M; Arnold R; Fehmann HC
Eur J Clin Invest; 2000 Aug; 30(8):729-39. PubMed ID: 10964166
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
